Synonyms: ADX-102 | ADX102 | example 5 [WO2018039197A1] | NS-2 | NS2 [1]
Compound class:
Synthetic organic
Comment: Reproxalap is a novel small molecule that acts as a molecular trap for pro-inflammatory Reactive Aldehyde Species (RASP) that was developed by Aldeyra Therapeutics. Reproxalap (as example 5; NS2) and its uses are claimed in Aldeyra patent WO2018039197A1 [1].
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
2-(3-amino-6-chloroquinolin-2-yl)propan-2-ol |
International Nonproprietary Names ![]() |
|
INN number | INN |
10698 | reproxalap |
Synonyms ![]() |
|
ADX-102 | ADX102 | example 5 [WO2018039197A1] | NS-2 | NS2 [1] |
Database Links ![]() |
|
CAS Registry No. | 916056-79-6 (source: WHO INN record) |
GtoPdb PubChem SID | 404859060 |
PubChem CID | 16088030 |
Search Google for chemical match using the InChIKey | GUHFUVLKYSQIOQ-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | GUHFUVLKYSQIOQ |
Search PubMed clinical trials | reproxalap |
Search PubMed titles | reproxalap |
Search PubMed titles/abstracts | reproxalap |
UniChem Compound Search for chemical match using the InChIKey | GUHFUVLKYSQIOQ-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | GUHFUVLKYSQIOQ-UHFFFAOYSA-N |